Lista de obras - Salud A - Dominio Público Uruguay

A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer

artículo científico

A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyond

artículo científico publicado en 2014

Accuracy of fluorodeoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: a meta-analysis

artículo científico publicado en 2015

Accuracy of pleural fluid cytology in malignant effusions

artículo científico publicado en 2008

Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study

artículo científico publicado en 2011

Antiemetic efficacy of subcutaneous 5-HT3 receptor antagonists in terminal cancer patients

artículo científico publicado en 1998

Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

artículo científico publicado en 2010

Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study

artículo científico publicado en 2015

Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial†.

artículo científico publicado en 2015

Clinical Impact of 18F-FDG-PET in the Suspicion of Recurrent Ovarian Carcinoma Based on Elevated Tumor Marker Serum Levels

artículo científico publicado en 2000

Clinical features and survival of lung cancer patients with pleural effusions

artículo científico publicado en 2015

Clinical guideline SEOM: hepatocellular carcinoma

artículo científico publicado en 2015

Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients.

artículo científico publicado en 2018

Correlation of hypertension and proteinuria with outcome in elderly bevacizumab-treated patients with metastatic colorectal cancer

artículo científico publicado en 2015

Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial.

artículo científico publicado en 2017

Endobronchial metastases in colorectal adenocarcinoma

artículo científico publicado el 31 de agosto de 1992

Endobronchial metastatic disease: analysis of 32 cases

scientific article published on 01 August 1996

First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study.

artículo científico publicado en 2014

Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group

artículo científico publicado en 2017

High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions

artículo científico publicado en 2008

Identifying Thoracic Malignancies Through Pleural Fluid Biomarkers: A Predictive Multivariate Model

artículo científico publicado en 2016

Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study.

artículo científico publicado en 2004

Level of HER2 gene amplification predicts response and overall survival in HER2-positive advanced gastric cancer treated with trastuzumab.

artículo científico publicado en 2013

MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial.

artículo científico publicado en 2017

Multiple drug resistance: current concepts and future perspectives

scientific article published on 01 May 1993

Novel biomarkers in primary breast core biopsies to predict poor response to neoadjuvant chemotherapy and appearance of metastases

artículo científico publicado en 2016

Orbital Metastases from Transitional-Cell Cancer of the Urinary Bladder

artículo científico publicado en 1991

Palliative sedation: Current situation and areas of improvement

artículo científico publicado en 2014

Phase II randomised trial of raltitrexed-oxaliplatin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancer.

artículo científico publicado en 2005

Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancer

artículo científico publicado en 2013

Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: the GEMCAD 0801 Phase II Multicenter Trial

artículo científico publicado en 2014

Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer

artículo científico publicado en 1999

Prognostic significance of pleural fluid data in patients with malignant effusion.

artículo científico publicado en 2007

Prognostic value of c-FLIPL/s, HIF-1α, and NF-κβ in stage II and III rectal cancer

artículo científico publicado en 2014

Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer.

artículo científico publicado en 2005

Recommendations and expert opinion on the adjuvant treatment of colon cancer in Spain ⬇️

artículo científico publicado el 1 de noviembre de 2011

Should a cytologic study be ordered in transudative pleural effusions?

artículo científico publicado en 1999

Solid neoplasms associated with multiple myeloma

artículo científico publicado en 1991

Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions

artículo científico publicado en 2005

TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions.

artículo científico publicado en 2015

Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions

artículo científico publicado en 2004

XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

artículo científico publicado en 2006

[Melanoma and hypopigmentation]

artículo científico publicado en 1993

[Pulmonary metastasising benign leiomyoma evolving to chronic respiratory failure]

scientific article published on 01 September 1997

[Thyroid metastasis as a form of presentation of renal cell carcinoma]

artículo científico publicado en 1991

[Treatment with interferon of systemic Langerhans-cell histiocytosis in an adult]

scientific article published on 01 February 1990

[Unilateral exophthalmos secondary to orbital metastasis as initial manifestation of breast cancer]

scientific article published on 01 March 2002

Lista de obras de Salud A

A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer

A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyond

Accuracy of fluorodeoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: a meta-analysis

Accuracy of pleural fluid cytology in malignant effusions

Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study

Antiemetic efficacy of subcutaneous 5-HT3 receptor antagonists in terminal cancer patients

Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study

Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial†.

Clinical Impact of 18F-FDG-PET in the Suspicion of Recurrent Ovarian Carcinoma Based on Elevated Tumor Marker Serum Levels

Clinical features and survival of lung cancer patients with pleural effusions

Clinical guideline SEOM: hepatocellular carcinoma

Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients.

Correlation of hypertension and proteinuria with outcome in elderly bevacizumab-treated patients with metastatic colorectal cancer

Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial.

Endobronchial metastases in colorectal adenocarcinoma

Endobronchial metastatic disease: analysis of 32 cases

First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study.

Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group

High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions

Identifying Thoracic Malignancies Through Pleural Fluid Biomarkers: A Predictive Multivariate Model

Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study.

Level of HER2 gene amplification predicts response and overall survival in HER2-positive advanced gastric cancer treated with trastuzumab.

MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial.

Multiple drug resistance: current concepts and future perspectives

Novel biomarkers in primary breast core biopsies to predict poor response to neoadjuvant chemotherapy and appearance of metastases

Orbital Metastases from Transitional-Cell Cancer of the Urinary Bladder

Palliative sedation: Current situation and areas of improvement

Phase II randomised trial of raltitrexed-oxaliplatin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancer.

Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancer

Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: the GEMCAD 0801 Phase II Multicenter Trial

Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer

Prognostic significance of pleural fluid data in patients with malignant effusion.

Prognostic value of c-FLIPL/s, HIF-1α, and NF-κβ in stage II and III rectal cancer

Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer.

Recommendations and expert opinion on the adjuvant treatment of colon cancer in Spain ⬇️

Should a cytologic study be ordered in transudative pleural effusions?

Solid neoplasms associated with multiple myeloma

Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions

TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions.

Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions

XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

[Melanoma and hypopigmentation]

[Pulmonary metastasising benign leiomyoma evolving to chronic respiratory failure]

[Thyroid metastasis as a form of presentation of renal cell carcinoma]

[Treatment with interferon of systemic Langerhans-cell histiocytosis in an adult]

[Unilateral exophthalmos secondary to orbital metastasis as initial manifestation of breast cancer]